Back to Show
PBS News Hour
What’s keeping biosimilar drugs from the U.S. market?
NewsHour looks at a revolutionary class of drugs called "biologics." Americans have been paying more for their benefits than patients in Europe or Asia some say, because the "generic" versions or "biosimilars" have not hit the U.S. market. Dr. Emily Senay looks into why there's a delay and when American consumers can expect discounts.
Sign up now for inspiring and thought-provoking media delivered straight to your inbox.
Support Provided By

57:46
May 29, 2025 - PBS News Hour full episode

57:46
May 28, 2025 - PBS News Hour full episode

57:46
May 27, 2025 - PBS News Hour full episode

57:46
May 26, 2025 - PBS News Hour full episode

26:45
May 25, 2025 - PBS News Weekend full episode

26:45
May 24, 2025 - PBS News Weekend full episode

57:46
May 23, 2025 - PBS News Hour full episode

57:46
May 22, 2025 - PBS News Hour full episode

57:46
May 21, 2025 - PBS News Hour full episode

57:46
May 20, 2025 - PBS News Hour full episode

57:46
May 19, 2025 - PBS News Hour full episode

26:45
May 18, 2025 - PBS News Weekend full episode